Request for a License To Export Deuterium, 79018-79019 [2013-31026]

Download as PDF 79018 Federal Register / Vol. 78, No. 249 / Friday, December 27, 2013 / Notices tkelley on DSK3SPTVN1PROD with NOTICES with the reduced radiological risk and protective strategy for a decommissioning facility or a standalone ISFSI. As discussed in the SER, and consistent with the Commission’s authority 10 CFR 73.5, the Commission is issuing exemptions from the following requirements:10 CFR 73.55(c)(5); 10 CFR 73.55(h)(3)(ii); 10 CFR(i)(2); 10 CFR 73.55(i)(4)(i); 10 CFR 73.55(i)(4)(ii)(G); 10 CFR 73.55(k)(5)(ii); 10 CFR 73.55(k)(5)(iii); 10 CFR 73.55(n)(i); 10 CFR 73.55(n)(ii); 10 CFR 73.55(n)(iii); 10 CFR 73.55(p)(1)(i); and 10 CFR 73.55(p)(ii). In Enclosure 1 to ZNPS letter of October 4, 2013, ZNPS requested that NRC affirm that specific exemptions previously granted to ZNPS for the defueled reactor as also applicable for the ZNPS ISFSI PSP. Specifically, the licensee requested affirmation of the exemptions to the following requirements for the ISFSI PSP: 10 CFR 73.55(b)(3)(i); 10 CFR 73.55(b)(4); 10 CFR 73.55(b)(6); 10 CFR 73.55(b)(9); 10 CFR 73.55(c)(4); 10 CFR 73.55(d)(3)(i); 10 CFR 73.55(e)–(e)(1)(i); 10 CFR 73.55(e)(7)(i)–(ii); 10 CFR 73.55(e)(9)(1)– (vi); 10 CFR 73.55(e)(10)(ii); 10 CFR 73.55(f)(1)–(4); 10 CFR 73.55(h)(2); 10 CFR 73.55(i); 10 CFR 73.55(i)(2); and 10 CFR 73.55(k)(1). The ZNPS ISFSI PSP is, however, a stand-alone security plan that has been evaluated against the requirements of 10 CFR part 73. No application of a previous exemption is necessary. Based on the evaluation in the associated safety evaluation, which considered the permanently shut-down and defueled conditions at the ZNPS, and the new ZNPS ISFSI facility where the fuel will be located within the protected area of the dry storage facility, the NRC has concluded that: (1) there is reasonable assurance that the health and safety of the public will not be endangered by granting said exemptions; (2) such activities will be conducted in compliance with the Commission’s regulations and orders; and (3) the approval of these exemptions will not be inimical to the common defense and security or the health and safety of the public and are otherwise in the public interest. These conclusions are discussed in greater detail in the staff’s SER. VerDate Mar<15>2010 23:48 Dec 26, 2013 Jkt 232001 4.0 Conclusion Accordingly, the Commission has determined that, pursuant to 10 CFR 73.5, an exemption is authorized by law, will not endanger life or property or the common defense and security, and is otherwise in the public interest based on permanently shut down and defueled conditions at the ZNPS. Therefore, the Commission hereby grants ZionSolutions an exemption from the requirements of 10 CFR part 73 as delineated above. Pursuant to 10 CFR 51.22(c)(25), the Commission has determined the granting of these exemptions is categorically excluded and pursuant to 10 CFR 51.22(b), no environmental impact statement or environmental assessment need be prepared. The exemption involves safeguard plans, as described in 10 CFR 51.22(c)(25)(vi)(F). Approval of this exemption request involves no significant hazards consideration; no significant change in the types or significant increase in the amounts of any effluents that may be released offsite; no significant increase in individual or cumulative public or occupational radiation exposure; no significant construction impact; and no significant increase in the potential for or consequences from radiological accidents. These exemptions are effective upon issuance. Dated at Rockville, Maryland, this 13th day of December 2013. For the Nuclear Regulatory Commission. Aby Mohseni, Deputy Director, Environmental Protection and Performance Assessment Directorate, Division of Waste Management and Environmental Protection, Office of Federal and State Materials and Environmental Management Programs. [FR Doc. 2013–31086 Filed 12–26–13; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Request for a License To Export Deuterium Regulatory Commission (NRC) has received the following request for an export license. Copies of the request are available electronically through ADAMS and can be accessed through the Public Electronic Reading Room (PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage. A request for a hearing or petition for leave to intervene may be filed within thirty days after publication of this notice in the Federal Register. Any request for hearing or petition for leave to intervene shall be served by the requestor or petitioner upon the applicant, the Office of the General Counsel, U.S. Nuclear Regulatory Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555; and the Executive Secretary, U.S. Department of State, Washington, DC 20520. A request for a hearing or petition for leave to intervene may be filed with the NRC electronically in accordance with NRC’s E-Filing rule promulgated in August 2007, 72 FR 49139 (Aug. 28, 2007). Information about filing electronically is available on the NRC’s public Web site at http://www.nrc.gov/ site-help/e-submittals.html. To ensure timely electronic filing, at least 5 (five) days prior to the filing deadline, the petitioner/requestor should contact the Office of the Secretary by email at HEARINGDOCKET@NRC.GOV, or by calling (301) 415–1677, to request a digital ID certificate and allow for the creation of an electronic docket. In addition to a request for hearing or petition for leave to intervene, written comments, in accordance with 10 CFR 110.81, should be submitted within thirty (30) days after publication of this notice in the Federal Register to Office of the Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555, Attention: Rulemaking and Adjudications. The information concerning this export license application follows. Pursuant to 10 CFR 110.70 (b) ‘‘Public Notice of Receipt of an Application,’’ please take notice that the U.S. Nuclear PO 00000 Frm 00209 Fmt 4703 Sfmt 4703 E:\FR\FM\27DEN1.SGM 27DEN1 79019 Federal Register / Vol. 78, No. 249 / Friday, December 27, 2013 / Notices NRC EXPORT LICENSE APPLICATION [Description of material] Name of applicant, date of application, date received, application no., docket no. Material type Concert Pharmaceuticals, Inc. ....................... August 29, 2013 ............................................. December 5, 2013 ......................................... XMAT431 ....................................................... 11006131 ....................................................... Dated this 20th day of December 2013 in Rockville, Maryland. For the Nuclear Regulatory Commission. Stephen Dembek, Acting Deputy Director, Office of International Programs. [FR Doc. 2013–31026 Filed 12–26–13; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards (ACRS) Meeting of the ACRS Subcommittee on Materials, Metallurgy & Reactor Fuels; Notice of Meeting The ACRS Subcommittee on Materials, Metallurgy & Reactor Fuels will hold a meeting on January 14, 2014, Room T–2B1, 11545 Rockville Pike, Rockville, Maryland. The meeting will be open to public attendance. The agenda for the subject meeting shall be as follows: tkelley on DSK3SPTVN1PROD with NOTICES Tuesday, January 14, 2014—1:00 p.m. until 5:00 p.m. The Subcommittee will discuss fuel research in support of the ACRS Biannual Review and Evaluation of Research Projects. The Subcommittee will hear presentations by and hold discussions with the NRC staff and other interested persons regarding this matter. The Subcommittee will gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the Full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official (DFO), Zena Abdullahi (Telephone 301–415–8716 or Email: Zena.Abdullahi@nrc.gov) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Thirty-five hard copies of each presentation or handout should be provided to the DFO thirty minutes VerDate Mar<15>2010 23:48 Dec 26, 2013 Jkt 232001 Total quantity Heavy water (D2O) .... ∼20,000.0 kgs ............ before the meeting. In addition, one electronic copy of each presentation should be emailed to the DFO one day before the meeting. If an electronic copy cannot be provided within this timeframe, presenters should provide the DFO with a CD containing each presentation at least thirty minutes before the meeting. Electronic recordings will be permitted only during those portions of the meeting that are open to the public. Detailed procedures for the conduct of and participation in ACRS meetings were published in the Federal Register on November 8, 2013 (78 FR 67205–67206). Detailed meeting agendas and meeting transcripts are available on the NRC Web site at http://www.nrc.gov/readingrm/doc-collections/acrs. Information regarding topics to be discussed, changes to the agenda, whether the meeting has been canceled or rescheduled, and the time allotted to present oral statements can be obtained from the Web site cited above or by contacting the identified DFO. Moreover, in view of the possibility that the schedule for ACRS meetings may be adjusted by the Chairman as necessary to facilitate the conduct of the meeting, persons planning to attend should check with these references if such rescheduling would result in a major inconvenience. If attending this meeting, please enter through the One White Flint North building, 11555 Rockville Pike, Rockville, MD. After registering with security, please contact Mr. Theron Brown (Telephone 240–888–9835) to be escorted to the meeting room. Dated: December 18, 2013. Cayetano Santos, Chief, Technical Support Branch, Advisory Committee on Reactor Safeguards. [FR Doc. 2013–31035 Filed 12–26–13; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00210 Fmt 4703 Sfmt 4703 End use Non-nuclear end-use in active pharmaceutical ingredient manufacturing.. Recipient country Portugal, Austria NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards (ACRS) Meeting of the ACRS Subcommittee on Materials, Metallurgy & Reactor Fuels; Notice of Meeting The ACRS Subcommittee on Materials, Metallurgy & Reactor Fuels will hold a meeting on January 14, 2014, Room T–2B1, 11545 Rockville Pike, Rockville, Maryland. The meeting will be open to public attendance. The agenda for the subject meeting shall be as follows: Tuesday, January 14, 2014–8:30 a.m. Until 12:00 p.m. The Subcommittee will discuss the NRC’s research activities in materials and metallurgy. The Subcommittee will hear presentations by and hold discussions with the NRC staff and other interested persons regarding this matter. The Subcommittee will gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the Full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official (DFO), Christopher Brown (Telephone 301–415–7111 or Email: Christopher.Brown@nrc.gov) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Thirty-five hard copies of each presentation or handout should be provided to the DFO thirty minutes before the meeting. In addition, one electronic copy of each presentation should be emailed to the DFO one day before the meeting. If an electronic copy cannot be provided within this timeframe, presenters should provide the DFO with a CD containing each presentation at least thirty minutes before the meeting. Electronic recordings will be permitted only during those portions of the meeting E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 78, Number 249 (Friday, December 27, 2013)]
[Notices]
[Pages 79018-79019]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-31026]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Request for a License To Export Deuterium

    Pursuant to 10 CFR 110.70 (b) ``Public Notice of Receipt of an 
Application,'' please take notice that the U.S. Nuclear Regulatory 
Commission (NRC) has received the following request for an export 
license. Copies of the request are available electronically through 
ADAMS and can be accessed through the Public Electronic Reading Room 
(PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage.
    A request for a hearing or petition for leave to intervene may be 
filed within thirty days after publication of this notice in the 
Federal Register. Any request for hearing or petition for leave to 
intervene shall be served by the requestor or petitioner upon the 
applicant, the Office of the General Counsel, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; and the Executive 
Secretary, U.S. Department of State, Washington, DC 20520.
    A request for a hearing or petition for leave to intervene may be 
filed with the NRC electronically in accordance with NRC's E-Filing 
rule promulgated in August 2007, 72 FR 49139 (Aug. 28, 2007). 
Information about filing electronically is available on the NRC's 
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To 
ensure timely electronic filing, at least 5 (five) days prior to the 
filing deadline, the petitioner/requestor should contact the Office of 
the Secretary by email at HEARINGDOCKET@NRC.GOV, or by calling (301) 
415-1677, to request a digital ID certificate and allow for the 
creation of an electronic docket.
    In addition to a request for hearing or petition for leave to 
intervene, written comments, in accordance with 10 CFR 110.81, should 
be submitted within thirty (30) days after publication of this notice 
in the Federal Register to Office of the Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555, Attention: Rulemaking and 
Adjudications.
    The information concerning this export license application follows.

[[Page 79019]]



                                         NRC Export License Application
                                            [Description of material]
----------------------------------------------------------------------------------------------------------------
   Name of applicant,  date of
  application,  date received,       Material type      Total quantity          End use        Recipient country
  application no.,  docket no.
----------------------------------------------------------------------------------------------------------------
Concert Pharmaceuticals, Inc....  Heavy water (D2O).  ~20,000.0 kgs.....  Non-nuclear end-    Portugal, Austria
August 29, 2013.................                                           use in active
December 5, 2013................                                           pharmaceutical
XMAT431.........................                                           ingredient
11006131........................                                           manufacturing..
----------------------------------------------------------------------------------------------------------------


     Dated this 20th day of December 2013 in Rockville, Maryland.
    For the Nuclear Regulatory Commission.

Stephen Dembek,
Acting Deputy Director, Office of International Programs.
[FR Doc. 2013-31026 Filed 12-26-13; 8:45 am]
BILLING CODE 7590-01-P